Differentiated thyroid cancer is characteristically associated with an innocuous clinical
course, but a minority of cases may manifest surprisingly aggressive behaviour. Such …

Introduction: Papillary and follicular thyroid carcinomas are the most common thyroid
malignancies and are usually indolent. Lymph-node involvement increases the rate of tumor …

Background: Surgical extent in the management of well-differentiated thyroid cancer (DTC)
remains a recurrent subject of debate. This is especially relevant in low-risk DTC of 1–4 cm …

Background: After initial surgical treatment of differentiated thyroid cancer (DTC) residual
lymph node metastases are often found at the time of radioactive iodine (131I) therapy …

To estimate survival of patients with loco-regional recurrences (LRRs) of differentiated
thyroid carcinomas (DTCs) and to identify factors associated with survival after LRRs, we …

Background To assess the gaps between the initial management of patients with
differentiated thyroid cancer (DTC) in real clinical practice and the recommendations of the …

Approximately 37,200 people are expected to be diagnosed with thyroid cancer in the
United States this year. 1 Prognosis largely depends on the degree of tumor differentiation …

Background: Facing the prevailing concept that increased diagnosis with no change in
mortality drives the increased incidence of differentiated thyroid cancer (DTC), considerable …

Background Surgery is still the only curative treatment for medullary thyroid cancer (MTC).
We evaluated clinical outcome in patients with locoregional MTC with regard to adequacy of …

The concept of individualized therapy is rapidly gaining recognition in the management of
patients with differentiated thyroid cancer (DTC). This Review provides an overview of the …